Combination therapy of cutaneous candidiasis in patients with concomitant systemic pathology
Meditsinskiy sovet = Medical Council · 16.04.2026 · (2) · 80-90
DOI: 10.21518/ms2026-098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 16.04.2026. Verfasst von Ju. S. Kovaleva und 4 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Candida fungus is an integral part of the normal human microbiome, but disruption of skin integrity and malperformance of immune function can transform it into a pathogenic form. Some Candida strains are capable of modulating the immune response through suppressing the production of proinflammatory cytokines and inducing T-helper differentiation toward a Th2 response, which contributes to the chronification of inflammation. In this article, we take a detailed look at exogenous and endogenous risk factors. Particular focus has been placed on comorbidities: the present-date knowledge on the role of Candida spp. in exacerbating the course of atopic dermatitis and psoriasis is provided. The authors presented clinical case reports of candidiasis treatment in patients with aggravated histories. Case report 1: a 19-year-old man with complaints of pain, redness, and swelling in the periungual fold area combined with changes in the color and texture of the nail plate. Diagnosis: Periungual fold candidiasis. Onychomycosis. Treatment with 2% sertaconazole cream was prescribed. After 4 weeks, clinical regression of the inflammation process and partial restoration of the nail plate structure was observed. Case report 2: a 37-year-old man with complaints of severe itching, burning, and redness in the groin folds. Diagnosis: Candidal intertrigo of the groin folds associated with antibiotic therapy due to obesity. The prescribed stepwise therapy included: 0.05% clotrimazole + 0.1% gentamicin + 1% betamethasone for 7 days, then 2% sertaconazole cream for 2 weeks. After a three-week therapy, the rash regressed and post-inflammatory hyperpigmentation developed in a patient. Case report 3: a 58-year-old woman with complains of intense itching, burning, pain, and oozing in the abdominal fold within 3 weeks. The patient's medical history told a story of chronic illness. Diagnosis: Candidal intertrigo. The prescribed stepwise therapy included: 0.05% clotrimazole + 0.1% gentamicin + 1% betamethasone for 7 days, then 2% sertaconazole cream for 2 weeks. After a three-week course of treatment, the inflammation regressed. In all cases, skin scrapings showed negative follow-up microscopic examination results.
Zitieren
APA
Kovaleva, J. S., Zyablitskaya, N. K., Orobei, M. V., Goltsov, R. E., & Savelyeva, P. D. (2026). Combination therapy of cutaneous candidiasis in patients with concomitant systemic pathology. Meditsinskiy sovet = Medical Council, 80-90. https://doi.org/10.21518/ms2026-098
Vancouver
Kovaleva JS, Zyablitskaya NK, Orobei MV, Goltsov RE, Savelyeva PD. Combination therapy of cutaneous candidiasis in patients with concomitant systemic pathology. Meditsinskiy sovet = Medical Council. 2026:80-90. doi:10.21518/ms2026-098
BibTeX
@article{Kovaleva2026,
author = {Kovaleva, Ju. S. and Zyablitskaya, N. K. and Orobei, M. V. and Goltsov, R. E. and Savelyeva, P. D.},
title = {Combination therapy of cutaneous candidiasis in patients with concomitant systemic pathology},
journal = {Meditsinskiy sovet = Medical Council},
year = {2026},
number = {2},
pages = {80--90},
doi = {10.21518/ms2026-098}
}
EUVIMED